Fig. 1From: A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustatStudy design. Subjects received S. boulardii or placebo alone (i.e., without miglustat) during the first 2Â days of each periodBack to article page